ARE Share Price Performance
US$53.97
-43.70 (-44.74%)
7.5% undervalued intrinsic discount
US$58.33
Fair Value
Price US$53.97
AnalystConsensusTarget US$58.33
AnalystHighTarget US$82.97
AnalystLowTarget US$71.00
Fair ValueUS$58.33
Share Pricen/a
Alexandria Real Estate Equities, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 128 Fair Values set on narratives written by author
ARE Community Narratives
AN
Fair Value US$58.33 7.5% undervalued intrinsic discount
Share Repurchase and Expansion Will Support Long-Term Prospects Amid Earnings Update
0users have liked this narrative
0users have commented on this narrative
77users have followed this narrative
AN
Fair Value US$82.97 35.0% undervalued intrinsic discount
Premier Innovation Hubs Will Fuel Long-Term Lab Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$71 24.0% undervalued intrinsic discount
Rising Financing Costs And Hybrid Trends Will Squeeze Returns
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Premier Innovation Hubs Will Fuel Long-Term Lab Demand
Key Takeaways Alexandria's strategy leverages heightened life sciences demand, with mega campus investments and aggressive asset recycling driving rent growth, occupancy, and significant earnings expansion. Outpaced demand for specialized lab spaces and durable, long-term leases with high-quality tenants ensure strong cash flow visibility and sustained earnings and dividend growth.Read more
52
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$82.97
35.0% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
-1.01% p.a.
Profit Margin
1.04%
Future PE
604.54x
Price in 2029
US$108.94
Share Repurchase and Expansion Will Support Long-Term Prospects Amid Earnings Update
Key Takeaways Premium assets in major innovation clusters secure long-term leases with top tenants, supporting stable cash flows and above-market rent growth. Rising demand for specialized lab space and high entry barriers strengthen Alexandria's competitive position and earnings potential.Read more
849
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
77users have followed this narrative
AN
US$58.33
7.5% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
-2.2% p.a.
Profit Margin
0.022%
Future PE
20.7kx
Price in 2028
US$76.84
Rising Financing Costs And Hybrid Trends Will Squeeze Returns
Key Takeaways Rising costs, regulatory pressures, and shifts in workplace demand are squeezing margins and threatening predictability of earnings and occupancy rates. Heavy dependence on key biotech hubs and evolving funding trends increases revenue volatility and prolongs vacancy risks.Read more
63
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
US$71
24.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
-1.63% p.a.
Profit Margin
5.9%
Future PE
87.23x
Price in 2028
US$90.48
Trending Discussion
Recently Updated Narratives
AN
ARE: Share Repurchases And Dividend Reset Will Support Future Upside Potential
Fair Value: US$82.97 35.0% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ARE: Dividend Reset And Buyback Will Drive Long Term Upside Potential
Fair Value: US$58.33 7.5% undervalued intrinsic discount
77 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Financing Costs And Hybrid Trends Will Squeeze Returns
Fair Value: US$71 24.0% undervalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Alexandria Real Estate Equities, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Jan 26, 2026
- -2.44
- 69.58%
- -13.77%
- 64.4%
About ARE
- Founded
- 1994
- Employees
- 552
- CEO
- WebsiteView website
Alexandria, an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
